References
- Lee S. W., Kim J. H., Park M. C., Park Y. B., Lee S. K. Adiponectin mitigates the severity of arthritis in mice with collagen‐induced arthritis. Scand J Rheumatol 2008; 37: 260–8
- Lewicki M., Kotyla P., Kucharz E. Etanercept increases adiponectin level in woman with rheumatoid arthritis. Clin Rheumatol 2008; 27: 1337–8
- Nagashima T., Okubo‐Fornbacher H., Aoki Y., Kamata Y., Kimura H., Kamimura T., et al. Increase in plasma levels of adiponectin after administration of anti‐tumor necrosis factor agents in patients with rheumatoid arthritis. J Rheumatol 2008; 35: 936–8
- Serelis J., Kontogianni M. D., Katsiougiannis S., Bletsa M., Tektonidou M. G., Skopouli F. N. Effect of anti‐TNF treatment on body composition and serum adiponectin levels of women with rheumatoid arthritis. Clin Rheumatol 2008; 27: 795–7
- Huang H., Park P. H., McMullen M. R., Nagy L. E. Mechanisms for the anti‐inflammatory effects of adiponectin in macrophages. J Gastroenterol Hepatol 2008; 23((Suppl 1))S50–3
- Jacobsson L. T., Turesson C., Nilsson J. A., Petersson I. F., Lindqvist E., Saxne T., et al. Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis. Ann Rheum Dis 2007; 66: 670–5
- Yamaguchi N., Kukita T., Li Y. J., Kamio N., Fukumoto S., Nonaka K., et al. Adiponectin inhibits induction of TNF‐α/RANKL‐stimulated NFATc1 via the AMPK signaling. FEBS Lett 2008; 582: 451–6
- Nishida K., Okada Y., Nawata M., Saito K., Tanaka Y. Induction of hyperadiponectinemia following long‐term treatment of patients with rheumatoid arthritis with infliximab (IFX), an anti‐TNF‐alpha antibody. Endocr J 2008; 55: 213–16
- Komai N., Morita Y., Sakuta T., Kuwabara A., Kashihara N. Anti‐tumor necrosis factor therapy increases serum adiponectin levels with the improvement of endothelial dysfunction in patients with rheumatoid arthritis. Mod Rheumatol 2007; 17: 385–90